Pharmaceutical preparations, namely, preparations for treating metabolic disorders, namely, diabetes and obesity; pharmaceutical preparations for the regulation of food intake; pharmaceutical preparations for the regulation of glucose production; pharmaceutical preparations used to modulate long-chain fatty acyl-CoA levels in the hypothalamus; pharmaceutical preparations used to agonize KATP channels in the hypothalamus; pharmaceutical preparations used to inhibit pyruvate dehydrogenase kinase (PDHK) in the hypothalamus; pharmaceutical preparations used to effect amino acid and other analyte sensing in the hypothalamus for the treatment of obesity and diabetes

'acid':73 'acyl':39 'acyl-coa':38 'agon':49 'amino':72 'analyt':76 'chain':36 'channel':51 'coa':40 'dehydrogenas':61 'diabet':10,87 'disord':8 'effect':71 'fatti':37 'food':19 'glucos':27 'hypothalamus':44,54,66,80 'inhibit':59 'intak':20 'katp':50 'kinas':62 'level':41 'long':35 'long-chain':34 'metabol':7 'modul':33 'name':3,9 'obes':12,85 'pdhk':63 'pharmaceut':1,13,21,29,45,55,67 'prepar':2,4,14,22,30,46,56,68 'product':28 'pyruv':60 'regul':17,25 'sens':77 'treat':6 'treatment':83 'use':31,47,57,69

ARCUATE

Owners

Goods & Services